Tyra Biosciences, Inc. · NASDAQ:TYRA
Canaan XI L.P. reported a 5.50% stake in Tyra Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Canaan XI L.P. reported a 5.50% stake in Tyra Biosciences, Inc., 2,930,444 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 2,930,444
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Canaan XI L.P. | 5.50% | 2,930,444 |
| Canaan Partners XI LLC | 5.50% | 2,930,444 |
| Canaan 2020+ Co-Investment L.P. - Series 7 | 0.80% | 443,885 |
| Canaan Partners 2020+ Co-Investment LLC | 0.80% | 443,885 |
Source
Related
- Tyra Biosciences, Inc.
- Canaan XI L.P.
- Tyra Biosciences, Inc. shareholders
- Schedule 13G/A · Canaan XI L.P. · Apr 24, 2026
- Schedule 13G/A · Canaan XI L.P. · Jan 21, 2025
- Schedule 13G · Bvf Partners L P · Sep 21, 2026
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026